ÂÜÀòÂÒÂ×

Mara G. is a seasoned clinical operations professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Director of Clinical Operations at Rapport Therapeutics, Mara has previously contributed as the Associate Director of Clinical Operations at Intellia Therapeutics, where significant progress was made in initiating a first-in-human Phase 1/2 AATD study utilizing CRISPR technology. Mara's background includes leadership roles in pivotal clinical trials at Regeneron, Precision BioSciences, and Target RWE Health Evidence Solutions, with a strong focus on study management, regulatory compliance, and cross-functional team collaboration. Educational qualifications include a Master of Public Health in Epidemiology from Columbia University and a Bachelor of Arts in Biology from Boston College.